Multidrug-resistant, Gram-negative Bacterial Infections
Infectious diseases caused by viral or bacterial pathogens are a major cause of death and morbidity worldwide and constitute an ever growing medical need. We are focusing on discovery, research and development of new anti-infective agents, targeting both the pathogen as well as the host immune defences. In this, we build on an industry-leading technology platform and on a rich legacy of research in this field, which produced some outstanding therapeutics in hepatitis B, influenza and multi-drug resistant bacterial infections.
If you have an opportunity for collaboration or an interesting technology, or if you have an asset in one of our areas of interest, we would like to hear from you.